Scientific overview of CBD pharmacology and clinical trials

Scientific overview of CBD pharmacology and clinical trials The passage provides general medical information about CBD and mentions pharmaceutical companies, but contains no specific allegations, financial flows, or connections to powerful officials. It offers no actionable investigative leads. Key insights: Describes the endocannabinoid system and CBD's mechanism of action.; Lists FDA‑approved CBD drug (Epidiolex) and companies conducting trials.; Notes safety profile and potential drug‑interaction risks at high doses.